The last decade of scientific research has dramatically improved our understanding of the aging process and that it is closely regulated by key metabolic proteins such as mechanistic target of rapamycin (mTOR), AMP-activated protein kinase (AMPK), and insulin/insulin growth factor (IGF) [7, 8], which are associated with age-related metabolic syndrome [9] and common to those found dysregulated in cancer [10]. The gene discussed is MTOR; the disease is cancer.